UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 25, 2024 4:00 P.M.

Form:	S-3
CIK: 0001737287 Company Name: Allogene Therapeutics, Inc. File Number: 333-277951